Sample, data use and protection in biobanking in Europe

Legal issues

Eleni Zika, Tobias Schulte in den Bäumen, Jane Kaye, Angela Brand, Dolores Ibarreta

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The sharing of samples and data stored in biobanks for research has implications for donor privacy, but also raises questions on the regulation of research within Europe. Many legal documents and principles within Europe, with a direct impact on biobanking, have not been developed specifically to support this activity. Moreover, while some new regulations have been set up at national level, there are many variations in the definitions, scope and purpose of these legal instruments. This has resulted in unnecessary hurdles for genome-based research, particularly if samples are shared across national borders. The question is also raised on whether new, specific legislative and governance frameworks designed for biobanking are needed, or whether it is sufficient to modify current general law and to develop specific guidelines or to accommodate issues raised by biobanking in the current regulation. A workshop with experts from academia and industry, lawyers, national data protection authorities, representatives from the European Commission and the European Data Protection Supervisor was held to review the existing legal bottlenecks and future needs of biobanking, with special regard to the collection, exchange and linkage of samples and data. This report presents highlights of the presentations and discussions from the workshop held in Sevilla, Spain, in March 2007 and the conclusions that followed. The or workshop focused on the internal linkage of data and samples stored in a biobank, and the external linkage of biobanks with secondary information resources, such as cancer registries.

Original languageEnglish
Pages (from-to)773-781
Number of pages9
JournalPharmacogenomics
Volume9
Issue number6
DOIs
Publication statusPublished - 2008

Fingerprint

Computer Security
Information Storage and Retrieval
Education
Research
Lawyers
Information Dissemination
Privacy
Spain
Registries
Industry
Tissue Donors
Genome
Guidelines
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Genetics(clinical)

Cite this

Zika, Eleni ; in den Bäumen, Tobias Schulte ; Kaye, Jane ; Brand, Angela ; Ibarreta, Dolores. / Sample, data use and protection in biobanking in Europe : Legal issues. In: Pharmacogenomics. 2008 ; Vol. 9, No. 6. pp. 773-781.
@article{8b61c684b47d4d2eba7e70f6b1c2d172,
title = "Sample, data use and protection in biobanking in Europe: Legal issues",
abstract = "The sharing of samples and data stored in biobanks for research has implications for donor privacy, but also raises questions on the regulation of research within Europe. Many legal documents and principles within Europe, with a direct impact on biobanking, have not been developed specifically to support this activity. Moreover, while some new regulations have been set up at national level, there are many variations in the definitions, scope and purpose of these legal instruments. This has resulted in unnecessary hurdles for genome-based research, particularly if samples are shared across national borders. The question is also raised on whether new, specific legislative and governance frameworks designed for biobanking are needed, or whether it is sufficient to modify current general law and to develop specific guidelines or to accommodate issues raised by biobanking in the current regulation. A workshop with experts from academia and industry, lawyers, national data protection authorities, representatives from the European Commission and the European Data Protection Supervisor was held to review the existing legal bottlenecks and future needs of biobanking, with special regard to the collection, exchange and linkage of samples and data. This report presents highlights of the presentations and discussions from the workshop held in Sevilla, Spain, in March 2007 and the conclusions that followed. The or workshop focused on the internal linkage of data and samples stored in a biobank, and the external linkage of biobanks with secondary information resources, such as cancer registries.",
author = "Eleni Zika and {in den B{\"a}umen}, {Tobias Schulte} and Jane Kaye and Angela Brand and Dolores Ibarreta",
year = "2008",
doi = "10.2217/14622416.9.6.773",
language = "English",
volume = "9",
pages = "773--781",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "6",

}

Zika, E, in den Bäumen, TS, Kaye, J, Brand, A & Ibarreta, D 2008, 'Sample, data use and protection in biobanking in Europe: Legal issues', Pharmacogenomics, vol. 9, no. 6, pp. 773-781. https://doi.org/10.2217/14622416.9.6.773

Sample, data use and protection in biobanking in Europe : Legal issues. / Zika, Eleni; in den Bäumen, Tobias Schulte; Kaye, Jane; Brand, Angela; Ibarreta, Dolores.

In: Pharmacogenomics, Vol. 9, No. 6, 2008, p. 773-781.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sample, data use and protection in biobanking in Europe

T2 - Legal issues

AU - Zika, Eleni

AU - in den Bäumen, Tobias Schulte

AU - Kaye, Jane

AU - Brand, Angela

AU - Ibarreta, Dolores

PY - 2008

Y1 - 2008

N2 - The sharing of samples and data stored in biobanks for research has implications for donor privacy, but also raises questions on the regulation of research within Europe. Many legal documents and principles within Europe, with a direct impact on biobanking, have not been developed specifically to support this activity. Moreover, while some new regulations have been set up at national level, there are many variations in the definitions, scope and purpose of these legal instruments. This has resulted in unnecessary hurdles for genome-based research, particularly if samples are shared across national borders. The question is also raised on whether new, specific legislative and governance frameworks designed for biobanking are needed, or whether it is sufficient to modify current general law and to develop specific guidelines or to accommodate issues raised by biobanking in the current regulation. A workshop with experts from academia and industry, lawyers, national data protection authorities, representatives from the European Commission and the European Data Protection Supervisor was held to review the existing legal bottlenecks and future needs of biobanking, with special regard to the collection, exchange and linkage of samples and data. This report presents highlights of the presentations and discussions from the workshop held in Sevilla, Spain, in March 2007 and the conclusions that followed. The or workshop focused on the internal linkage of data and samples stored in a biobank, and the external linkage of biobanks with secondary information resources, such as cancer registries.

AB - The sharing of samples and data stored in biobanks for research has implications for donor privacy, but also raises questions on the regulation of research within Europe. Many legal documents and principles within Europe, with a direct impact on biobanking, have not been developed specifically to support this activity. Moreover, while some new regulations have been set up at national level, there are many variations in the definitions, scope and purpose of these legal instruments. This has resulted in unnecessary hurdles for genome-based research, particularly if samples are shared across national borders. The question is also raised on whether new, specific legislative and governance frameworks designed for biobanking are needed, or whether it is sufficient to modify current general law and to develop specific guidelines or to accommodate issues raised by biobanking in the current regulation. A workshop with experts from academia and industry, lawyers, national data protection authorities, representatives from the European Commission and the European Data Protection Supervisor was held to review the existing legal bottlenecks and future needs of biobanking, with special regard to the collection, exchange and linkage of samples and data. This report presents highlights of the presentations and discussions from the workshop held in Sevilla, Spain, in March 2007 and the conclusions that followed. The or workshop focused on the internal linkage of data and samples stored in a biobank, and the external linkage of biobanks with secondary information resources, such as cancer registries.

UR - http://www.scopus.com/inward/record.url?scp=48949119309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48949119309&partnerID=8YFLogxK

U2 - 10.2217/14622416.9.6.773

DO - 10.2217/14622416.9.6.773

M3 - Article

VL - 9

SP - 773

EP - 781

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 6

ER -